Standard

МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ. / Boytsov, S.A.; Vavilova, T.V.; Gurevich, V.S.; Drapkina, O.M.; Drozdova, L.Yu.; Yezhov, M.V.; Zvartau, N.E.; Sergienko, I.V.

In: ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА, Vol. 28, No. 4, 2025, p. 7-15.

Research output: Contribution to journal › Article › peer-review

Harvard

Boytsov, SA, Vavilova, TV, Gurevich, VS, Drapkina, OM, Drozdova, LY, Yezhov, MV, Zvartau, NE & Sergienko, IV 2025, 'МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ', ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА, vol. 28, no. 4, pp. 7-15. https://doi.org/10.17116/profmed2025280417

APA

Boytsov, S. A., Vavilova, T. V., Gurevich, V. S., Drapkina, O. M., Drozdova, L. Y., Yezhov, M. V., Zvartau, N. E., & Sergienko, I. V. (2025). МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ. ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА, 28(4), 7-15. https://doi.org/10.17116/profmed2025280417

Vancouver

Boytsov SA, Vavilova TV, Gurevich VS, Drapkina OM, Drozdova LY, Yezhov MV et al. МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ. ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА. 2025;28(4):7-15. https://doi.org/10.17116/profmed2025280417

Author

Boytsov, S.A. ; Vavilova, T.V. ; Gurevich, V.S. ; Drapkina, O.M. ; Drozdova, L.Yu. ; Yezhov, M.V. ; Zvartau, N.E. ; Sergienko, I.V. / МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ. In: ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА. 2025 ; Vol. 28, No. 4. pp. 7-15.

BibTeX

@article{a7974f8d50514dbabd3f5e5cd4a9db28,
title = "МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ",
abstract = "The main focus for reducing the incidence of cardiovascular diseases (CVD) associated with atherosclerosis is early stratification of the CVD risk, timely detection of lipid metabolism disorders, and medical care for patients with a high and very high risk of developing such diseases. High-density lipoprotein cholesterol (HDL-C) was previously considered a risk factor for atherosclerosis; how ever, recently, high triglycerides and non-high-density lipoprotein cholesterol (NHDL-C) have also become important risk factors. This Resolution of the Panel of Experts reflects the roles of triglycerides and non-HDL cholesterol in cardiovascular risk assessment. {\textcopyright} 2025, Media Sphera Publishing Group. All rights reserved.",
keywords = "atherosclerosis, cardiovascular risk, hypertriglyceridemia, lipid metabolism disorders, triglyceride-rich particles, high density lipoprotein cholesterol, non high density lipoprotein cholesterol, triacylglycerol, unclassified drug, Article, cardiovascular disease, disorders of lipid and lipoprotein metabolism, high risk patient, human, incidence, risk assessment, risk factor",
author = "S.A. Boytsov and T.V. Vavilova and V.S. Gurevich and O.M. Drapkina and L.Yu. Drozdova and M.V. Yezhov and N.E. Zvartau and I.V. Sergienko",
note = "Export Date: 05 February 2026; Cited By: 0; Correspondence Address: L.Yu. Drozdova; National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russian Federation; email: ldrozdova@gnicpm.ru",
year = "2025",
doi = "10.17116/profmed2025280417",
language = "русский",
volume = "28",
pages = "7--15",
journal = "ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА",
issn = "2305-4948",
publisher = "Медиа Сфера",
number = "4",

}

RIS

TY - JOUR

T1 - МЕСТО ХОЛЕСТЕРИНА, НЕ СВЯЗАННОГО С ЛИПОПРОТЕИНАМИ ВЫСОКОЙ ПЛОТНОСТИ, И ТРИГЛИЦЕРИДОВ В ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА: РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ

AU - Boytsov, S.A.

AU - Vavilova, T.V.

AU - Gurevich, V.S.

AU - Drapkina, O.M.

AU - Drozdova, L.Yu.

AU - Yezhov, M.V.

AU - Zvartau, N.E.

AU - Sergienko, I.V.

N1 - Export Date: 05 February 2026; Cited By: 0; Correspondence Address: L.Yu. Drozdova; National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russian Federation; email: ldrozdova@gnicpm.ru

PY - 2025

Y1 - 2025

N2 - The main focus for reducing the incidence of cardiovascular diseases (CVD) associated with atherosclerosis is early stratification of the CVD risk, timely detection of lipid metabolism disorders, and medical care for patients with a high and very high risk of developing such diseases. High-density lipoprotein cholesterol (HDL-C) was previously considered a risk factor for atherosclerosis; how ever, recently, high triglycerides and non-high-density lipoprotein cholesterol (NHDL-C) have also become important risk factors. This Resolution of the Panel of Experts reflects the roles of triglycerides and non-HDL cholesterol in cardiovascular risk assessment. © 2025, Media Sphera Publishing Group. All rights reserved.

AB - The main focus for reducing the incidence of cardiovascular diseases (CVD) associated with atherosclerosis is early stratification of the CVD risk, timely detection of lipid metabolism disorders, and medical care for patients with a high and very high risk of developing such diseases. High-density lipoprotein cholesterol (HDL-C) was previously considered a risk factor for atherosclerosis; how ever, recently, high triglycerides and non-high-density lipoprotein cholesterol (NHDL-C) have also become important risk factors. This Resolution of the Panel of Experts reflects the roles of triglycerides and non-HDL cholesterol in cardiovascular risk assessment. © 2025, Media Sphera Publishing Group. All rights reserved.

KW - atherosclerosis

KW - cardiovascular risk

KW - hypertriglyceridemia

KW - lipid metabolism disorders

KW - triglyceride-rich particles

KW - high density lipoprotein cholesterol

KW - non high density lipoprotein cholesterol

KW - triacylglycerol

KW - unclassified drug

KW - Article

KW - cardiovascular disease

KW - disorders of lipid and lipoprotein metabolism

KW - high risk patient

KW - human

KW - incidence

KW - risk assessment

KW - risk factor

UR - https://elibrary.ru/item.asp?id=82291980

U2 - 10.17116/profmed2025280417

DO - 10.17116/profmed2025280417

M3 - статья

VL - 28

SP - 7

EP - 15

JO - ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА

JF - ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА

SN - 2305-4948

IS - 4

ER -

ID: 149036236